Carbonic Anhydrase Activators:  Design of High Affinity Isozymes I, II, and IV Activators, Incorporating Tri-/Tetrasubstituted-pyridinium-azole Moieties

Journal of Medicinal Chemistry
2002.0

Abstract

A series of tight binding carbonic anhydrase (CA) activators was obtained by reaction of amino-azoles (3-amino-pyrazole, 2-amino-imidazole, and 5-amino-tetrazole) with tri- or tetrasubstituted pyrylium salts. Many of the new pyridinium salts incorporating azole moieties reported here proved to be efficient in vitro activators of three CA isozymes, CA I, II, and IV. Very good activity was detected against hCA I and bCA IV (h = human; b = bovine isozymes), for which some of the new compounds showed affinities in the low nanomolar range, whereas against hCA II, their affinities were in the range of 95-150 nM. Substitution patterns of the pyridinium ring leading to best activity included 4-phenyl-2,6-dialkyl moieties or 2,4,6-tri- and 2,3,4,6-tetraalkyl groups. Ex vivo experiments showed some of the new activators to strongly enhance CA activity after incubation with human erythrocytes. Furthermore, due to their cationic nature, some of these compounds (the imidazole and pyrazole derivatives) are membrane-impermeant, discriminating thus between cytosolic and membrane-bound CA isozymes. The present paper is the first report of membrane-impermeant CA activators. The pyridinium tetrazole derivatives on the other hand do penetrate through biological membranes. Such CA activators might lead to the development of drugs/diagnostic tools for the management of CA deficiency syndromes as well as for the pharmacological enhancement of synaptic efficacy, spatial learning, and memory. This may constitute a new approach for the treatment of Alzheimer disease and other conditions in need of achieving memory therapy.

Knowledge Graph

Similar Paper

Carbonic Anhydrase Activators:  Design of High Affinity Isozymes I, II, and IV Activators, Incorporating Tri-/Tetrasubstituted-pyridinium-azole Moieties
Journal of Medicinal Chemistry 2002.0
Carbonic Anhydrase Activators:  High Affinity Isozymes I, II, and IV Activators, Incorporating a β-Alanyl-histidine Scaffold
Journal of Medicinal Chemistry 2002.0
Carbonic anhydrase activators: Activation of the human cytosolic isozyme III and membrane-associated isoform IV with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2008.0
Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators
Bioorganic & Medicinal Chemistry 2017.0
Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IX
Journal of Medicinal Chemistry 2004.0
α-Carbonic anhydrases are strongly activated by spinaceamine derivatives
Bioorganic & Medicinal Chemistry 2019.0
Carbonic anhydrase activators: Activation of human isozymes I, II and IX with phenylsulfonylhydrazido l-histidine derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Carbonic Anhydrase Inhibitors:  Synthesis of Membrane-Impermeant Low Molecular Weight Sulfonamides Possessing in Vivo Selectivity for the Membrane-Bound versus Cytosolic Isozymes
Journal of Medicinal Chemistry 2000.0
Carbonic anhydrase activators: Activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties
Bioorganic & Medicinal Chemistry Letters 1999.0